Metabolism of Monoamine Oxidase Inhibitors

@article{Baker2004MetabolismOM,
  title={Metabolism of Monoamine Oxidase Inhibitors},
  author={G. Baker and L. Urichuk and K. F. McKenna and S. H. Kennedy},
  journal={Cellular and Molecular Neurobiology},
  year={2004},
  volume={19},
  pages={411-426}
}
  • G. Baker, L. Urichuk, +1 author S. H. Kennedy
  • Published 2004
  • Chemistry, Medicine
  • Cellular and Molecular Neurobiology
    • Abstract1. The principal routes of metabolism of the following monoamine oxidase inhibitors (MAOIs) are described: phenelzine, tranylcypromine, pargyline, deprenyl, moclobemide, and brofaromine.2. Acetylation of phenelzine appears to be a minor metabolic pathway. Phenelzine is a substrate as well as an inhibitor of MAO, and major identified metabolites of phenelzine include phenylacetic acid and p-hydroxyphenylacetic acid. Phenelzine also elevates brain GABA levels, and as yet unidentified… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    61 Citations
    Highly Influencial Citations
    4
    Background Citations
    23
    Results Citations
    1
    61 Citations
    Citation Type

    Citation Type

    CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL/6 mouse and human liver microsomes.
    • S. Dragoni, G. Materozzi, +5 authors M. Valoti
    • Biology, Medicine
    • Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
    • 2007
    • 9
    • PDF
    N2-Acetylphenelzine : effects on rat brain GABA, alanine and biogenic amines
    • 16
    Synthesis and Biochemical Evaluation of Fluorinated Monoamine Oxidase Inhibitors
    • 4
    Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
    • 70
    • PDF
    An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.
    • 57
    Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosine.
    • 43
    • PDF
    Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    • 51
    • PDF
    Fluorinated Phenylcyclopropylamines as Inhibitors of Monoamine Oxidases
    • 26
    On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.
    • 29
    Biotransformation of the Analgesic-Antipyretic Drugs Metamizole and Aminopyrine by Genetically Polymorphic Enzymes
    • PDF

    References

    SHOWING 1-10 OF 135 REFERENCES
    Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    • 3
    The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro.
    • 51
    Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
    • 103
    Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline.
    • 24
    • Highly Influential
    Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N,alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6.
    • 60
    • Highly Influential
    Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    • 34
    Metabolism of (‐) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit
    • 137
    N‐propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl
    • F. Karoum
    • Chemistry, Medicine
    • British journal of pharmacology
    • 1987
    • 12
    Free radical pathways in the in vitro hepatic metabolism of phenelzine.
    • 13
    Enzymatic N-methylation of phenelzine catalyzed by methyltransferases from adrenal and other tissues.
    • P. Yu, B. Davis, D. Durden
    • Chemistry, Medicine
    • Drug metabolism and disposition: the biological fate of chemicals
    • 1991
    • 8